Abstract
The NuPulseCV iVAS is a minimally invasive, ambulatory, 50cc counterpulsation device. It provides extended duration support for advanced CHF(aCHF) patients. It is unknown which aCHF patients would respond favorably to counterpulsation. We, therefore, reviewed the early clinical iVAS trial data to determine which pre-implant parameters could predict hemodynamic success.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
